These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6324823)

  • 1. A murine model of polymyositis induced by coxsackievirus B1 (Tucson strain).
    Strongwater SL; Dorovini-Zis K; Ball RD; Schnitzer TJ
    Arthritis Rheum; 1984 Apr; 27(4):433-42. PubMed ID: 6324823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coxsackievirus B1-induced murine myositis: no evidence for viral persistence.
    Zoll J; Jongen P; Galama J; van Kuppeveld F; Melchers W
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2071-6. PubMed ID: 8409931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coxsackievirus B 1 induced murine polymyositis: acute infection with active virus is required for myositis.
    Ytterberg SR
    J Rheumatol; 1987 Feb; 14(1):12-8. PubMed ID: 3033235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coxsackie B1 virus-induced murine myositis: relationship of disease severity to virus dose and antiviral antibody response.
    Jongen PJ; Heessen FW; ter Laak HJ; Galama JM; Gabreëls FJ
    Neuromuscul Disord; 1994 Jan; 4(1):17-23. PubMed ID: 8173348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective polymyositis inducted by coxsackievirus B1 in mice.
    Ray CG; Minnich LL; Johnson PC
    J Infect Dis; 1979 Aug; 140(2):239-43. PubMed ID: 225392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coxsackievirus B 1-induced polymyositis. Lack of disease expression in nu/nu mice.
    Ytterberg SR; Mahowald ML; Messner RP
    J Clin Invest; 1987 Aug; 80(2):499-506. PubMed ID: 3038960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of virus persistence and its relationship to inflammation in the chronic phase of coxsackievirus B1-induced murine polymyositis.
    Tam PE; Schmidt AM; Ytterberg SR; Messner RP
    J Lab Clin Med; 1994 Mar; 123(3):346-56. PubMed ID: 8133145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cells are required for coxsackievirus B1 induced murine polymyositis.
    Ytterberg SR; Mahowald ML; Messner RP
    J Rheumatol; 1988 Mar; 15(3):475-8. PubMed ID: 2837572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coxsackie B1 virus-induced murine myositis: a correlative study of muscular lesions and serological changes.
    Jongen PJ; Heessen FW; Bergmann I; de Waal RM; ter Laak HJ; Galama JM; van Venrooij WJ; Gabreels FJ; van de Putte LB; Berden JH
    J Autoimmun; 1994 Dec; 7(6):727-37. PubMed ID: 7888031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Masquerade of Infectious Myositis as Polymyositis.
    Mank VMF; Brown KF; Roberts J
    Am J Trop Med Hyg; 2020 Nov; 103(5):1753. PubMed ID: 33205740
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic determinants of susceptibility to coxsackievirus B1-induced chronic inflammatory myopathy: effects of host background and major histocompatibility complex genes.
    Tam PE; Messner RP
    J Lab Clin Med; 1996 Sep; 128(3):279-89. PubMed ID: 8783635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral persistence during the developmental phase of Coxsackievirus B1-induced murine polymyositis.
    Tam PE; Schmidt AM; Ytterberg SR; Messner RP
    J Virol; 1991 Dec; 65(12):6654-60. PubMed ID: 1942249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic polymyositis: presence of coxsackievirus A9 antigen in muscle.
    Kuroda Y; Neshige R; Oda K; Shibasaki H
    Jpn J Med; 1986 May; 25(2):191-4. PubMed ID: 3018337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominant right leg dysfunction without asymmetric muscle inflammation in CD1 Swiss mice with coxsackievirus B1-induced myositis.
    Jongen PJ; Eling P; Van de Putte LB
    Physiol Behav; 1996; 59(4-5):763-8. PubMed ID: 8778864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of chronic myocarditis in mice infected with coxsackie B3 viruses.
    Jaśkiewicz K
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):89-97. PubMed ID: 220933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental arthrogryposis caused by viral myopathy.
    Drachman DB; Weiner LP; Price DL; Chase J
    Arch Neurol; 1976 May; 33(5):362-7. PubMed ID: 1267622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coxsackievirus B1-induced chronic inflammatory myopathy: differences in induction of autoantibodies to muscle and nuclear antigens by cloned myopathic and amyopathic viruses.
    Tam PE; Fontana DR; Messner RP
    J Lab Clin Med; 2003 Sep; 142(3):196-204. PubMed ID: 14532908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute viral polymyositis with predominant diaphragm involvement.
    De Reuck J; De Coster W; Inderadjaja N
    J Neurol Sci; 1977 Sep; 33(3):453-60. PubMed ID: 915529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coxsackievirus infection of mice. II. Viral kinetics and histopathological changes in mice experimentally infected with coxsackievirus B3 by intraperitoneal route.
    Vargová A; Bopegamage S; Borsanyiová M; Petrovicová A; Benkovicová M
    Acta Virol; 2003; 47(4):253-7. PubMed ID: 15068381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coxsackievirus-induced chronic inflammatory myopathy: virus variants distinguish between acute cytopathic effects and pathogenesis of chronic disease.
    Tam PE; Messner RP
    Virology; 1997 Jun; 233(1):199-209. PubMed ID: 9201230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.